Col-118
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Col-118, covering 2014-08-07 to 2014-08-07. Get the full timeline:
Most recent: Clinical Trial Update: Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2% [Phase 2]